The Muscular Dystrophy Association celebrates the FDA approval of Evrysdi in tablet form, a more accessible treatment option ...

A study at Lund University reveals that traumatic brain injury alters the small vessels in the brain, resulting in an accumulation of amyloid beta—a hallmark of Alzheimer's disease. The findings ...

InMed Pharmaceuticals Inc., a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug ...

Take a look around your home and you'll find yourself surrounded by familiar comforts—photos of family and friends on the ...

New research shows that inhaling polluted air for just an hour can impair cognitive abilities like attention and emotional ...

Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries Evrysdi tablet can be ...

Discover how Quietum Plus supports ear health and reduces tinnitus. Read my honest Quietum Plus reviews before you decide.

Paradromics, Inc., a global leader in high-data rate brain-computer interface (BCI) technology, announced a strategic ...

Paradromics announced today that it received a strategic investment from NEOM, a region taking shape in Saudi Arabia.

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for an Evrysdi® ...

A new study has discovered in mouse models that genes associated with repairing mismatched DNA are critical in eliciting damages to neurons that are most vulnerable in Huntington's disease and ...

Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries Evrysdi tablet can be stored at room temperature and offers the same demonstrated efficacy and sa ...